Market View

The U.S. market is in a Rally Attempt. The S&P 500 and Nasdaq held above a new low (S&P 500: 3,886; Nasdaq: 11,471) for three sessions, regaining multiple key moving averages Friday. The market status can now be upgraded to Confirmed Uptrend should a follow-through day (+1.7% in higher day/day volume) occur as early as Monday. Conversely, the market status will shift back to Downtrend should recent lows undercut.

Market View

The U.S. market is in a Downtrend. The S&P 500 and Nasdaq closed below their respective 50-DMA (S&P 500: 4,020;
Nasdaq: 12,030) on Tuesday, resulting in a downgrade of the market status. That level is now acting as near-term
resistance, though multiple moving averages are set to cross below in the coming days.

O’Neil Health Care Weekly

XLV fell 4.2% last week, breaking below all key moving averages including the 50-DMA at $129.78. This will now act as near-term
resistance. We view support between $124 to $125. Though the relative strength line (vs S&P 500) has flattened over the last two weeks, it
has not made a higher high, still warranting an equal to underweight sector positioning. Should broader market weakness persist, this
recommendation will likely change to overweight given the defensive profile of Health Care.

Market View

The U.S. market is in an Uptrend Under Pressure. The S&P 500 and Nasdaq fell for a second straight week, still
pulling back from 200-DMA resistance and now approaching a rising 50-DMA (S&P 500: 3,996; Nasdaq: 11,943). The
market status will be downgraded to Downtrend should indices close below this key level of support. The distribution day
count stands at four and five, respectively, with one day expiring on each index Monday.

O’Neil Health Care Weekly

XLV pulled back 52bps last week, trading relatively flat and holding above all key moving averages. We see nearterm support at ~$132 followed by the 50-DMA at $129.15. Near-term resistance is ~$134. Though the relative strength line (vs S&P 500) did tick up last week, it has not made a higher high, still warranting an equal to underweight sector positioning. Should broader market weakness persist, this recommendation will likely change to overweight given the defensive profile of Health Care.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq pulled back from 200-DMA (S&P 500:
4,321; Nasdaq: 13,447) resistance this week following four straight weeks of strong gains. The next level of support below
the 10-DMA is the rising 21-DMA (S&P 500: 4,157; Nasdaq: 12,560). The distribution day count stands at three and five,
respectively, with one day expiring on the Nasdaq next week.

O’Neil Health Care Weekly

XLV gained 1.6% last week clearing above the 200-DMA ($132.23), but still below price resistance at ~$134. There are
multiple moving averages between $129-$132 to act as near-term support. The relative strength line continues to trend
lower over the trailing six-weeks, still warranting an equal to underweight sector positioning.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq gained ~3% each for the week, rallying for the fourth straight week and nearing 200-DMA resistance (S&P 500: 4,329; Nasdaq: 13,510). Indices have become short-term extended versus 10- and 21-DMA support (S&P 500: 4,085; Nasdaq: 12,322). The distribution day count now stands at four and five, respectively, with two days expiring on the S&P 500 and one on the Nasdaq next week.

O’Neil Health Care Weekly

XLV pulled back 72 bps last week after finding resistance at its 200-DMA ($132.21). The index faces resistance at
that level up to ~$134. Support remains the 50-DMA ($128.84) before the $124-$125 range. The relative strength
line continues to trend lower over the trailing one-month, still warranting a reduction in sector weight.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 traded relatively flat this week, consolidating sharp July gains constructively above all near-term moving averages. This index still faces resistance at 4,177, or June highs. The Nasdaq traded higher for a third straight week with now no clear resistance until a falling 200-DMA (13,570). The sharply rising 10- and 21-DMA (S&P 500: 4,015; Nasdaq: 12,039) will act as near-term support for both indices. The distribution day count stands at five and three, respectively, with no expiration next week. There will however be three days expiring on the S&P 500 the following week.